AVITA Medical, Inc. (RCEL): Cash & Equivalents
$10.24M
As of 2025-12-31
$9.14M
As of 2026-06-30
-17.4%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.24M | -27.1% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $14.05M | -36.5% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $22.12M | +21.8% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $18.16M | -67.3% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $55.51M | n/a | 2023-02-23, Balance as of period end |
| 2021-06-30 | $110.75M | +50.4% | 2023-02-23, Balance as of period end |
| 2020-06-30 | $73.64M | +265.0% | 2021-08-26, Balance as of period end |
| 2019-06-30 | $20.17M | n/a | 2020-08-27, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $10.24M | -27.1% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $91.97M | -23.6% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $8.19M | n/m |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $50.84M | -3.5% |
| Iradimed Corp (IRMD) | 2025-12-31 | $51.16M | -2.1% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $43.45M | +34.1% |
| LENSAR, Inc. (LNSR) | 2025-12-31 | $12.97M | -20.2% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $69.75M | -1.6% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $75.71M | -28.5% |
Compare RCEL, SGHT, PDEX, TELA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗